Synthesis method of fosaprepitant dimeglumine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- LIANYUNGANG GUIKE PHARMA
- Publication Date
- 2020-09-15
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, in particular to a method for synthesizing fosaprepitant dipglumine. Background technique
[0002] Fosaprepitant Diglumine is a water-soluble phosphoryl prodrug of Aprepitant. After intravenous injection, it can be quickly converted into Aprepitant through phosphorylation in the body. It is suitable for patients who cannot be taken orally, Patients with difficulty swallowing or poor digestion. Fosaprepitant dimglumine and aprepitant belong to a group of selective high-affinity receptor blockers called human substance P / neurokinin 1 (NK-1), which mainly block nausea and vomiting signals in the brain mechanism of action.
[0003] At present, most of the synthesis methods of fosaprepitant dimeglumine reported in the literature are palladium-catalyzed hydrogenation in the last step, which requires high-pressure reactors, has poor safety, and the production scale is severely limited, so it is not s...